Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

CBC, November 25, 2020

While the development of a COVID-19 vaccine could generate billions of dollars for some pharmaceutical companies such as Pfizer, concerns over accusations of exploiting the pandemic will likely temper profits, experts suggest. "It doesn't really make sense to profit from this pandemic," said Tinglong Dai, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore.

What's the Science Behind COVID Business Capacity Limits?

What's the Science Behind COVID Business Capacity Limits?

Las Vegas Review-Journal, November 25, 2020

New restrictions imposed on restaurants and other businesses this week by Gov. Steve Sisolak to curb the spread of COVID-19 raise a question: What’s the science behind them? The science is imperfect, broad in stroke and balanced by policy and political considerations, health authorities said. “The basic idea is we are trying to reduce the density of people in any environment,” said epidemiologist Brian Labus, a member of the governor’s medical advisory team on COVID-19.

Vaccine Resisters Could Derail Island's COVID-19 Recovery, Experts Say

Vaccine Resisters Could Derail Island's COVID-19 Recovery, Experts Say

Newsday, November 29, 2020

Delivering an effective vaccine is only part of the equation. The region's recovery from COVID-19 also will hinge on Long Islanders' willingness to take the shot, experts say. The public's appetite for inoculations will be a wild card, said Julie Swann, an expert in health care supply chains who advised the Centers for Disease Control and Prevention during the H1N1 outbreak in 2009.

Pfizer's COVID Vaccine Comes With a Chilly Complication. But That May Change.

Pfizer's COVID Vaccine Comes With a Chilly Complication. But That May Change.

Fortune, November 28, 2020

Pfizer’s coronavirus vaccine candidate, announced earlier this month, comes with a major complication that could delay its distribution in rural areas and developing countries: It must be stored at the ultra-cold temperature of -70°C. That means the vaccine must be kept in specialized freezers that cost as much as $20,000 each and are rare outside of medical research facilities.

What Will It Take to Get a COVID-19 Vaccine to the World?

What Will It Take to Get a COVID-19 Vaccine to the World?

New Scientist, November 18, 2020

In Kalamazoo, Michigan, millions of vials of a covid-19 vaccine may soon be rolling off production lines. There are still many hurdles to leap before that vaccine – the candidate from US drug company Pfizer and its German partner BioNTech – or any other is approved and distributed, but governments, manufacturers and shipping firms around the world have already spent months preparing for what happens next.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

Study finds ChatGPT mirrors human decision biases in half the tests

Study finds ChatGPT mirrors human decision biases in half the tests

Celebrity Gig, April 2, 2025

Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations—showing biases like overconfidence of hot-hand (gambler’s) fallacy—yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

TIME, March 26, 2025

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely personal user data could be up for sale—and that vast trove of genetic data could draw interest from AI companies looking to train their data sets, experts say.

Healthcare

Want to reduce the cost of healthcare? Start with our billing practices.

Want to reduce the cost of healthcare? Start with our billing practices.

The Hill, March 11, 2025

Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive. 

We all benefit from and are hurt by health insurance claim denials

We all benefit from and are hurt by health insurance claim denials

Atlanta Journal Constitution, January 23, 2025

Health insurance has become necessary, with large and unpredictable health care costs always looming before each of us. Unfortunately, the majority of people have experienced problems when using their health insurance to pay for their medical care. Health insurance serves as the buffer between patients and the medical care system, using population pooling to mitigate the risk exposure on any one individual.

Supply Chain

Climate